Treating type 2 patients 2017-style
The increasing complexity of diabetes management and the expanding number of antihyperglycaemic medication options for type 2 diabetes can be a challenge for doctors.
So a team of Harvard-led diabetes experts have got together to provide some simple guidelines for managing and treating the disease.
Here they are:
- Metformin is an optimal first-line agent.
- Newer glucagon-like peptide-1 and sodium–glucose transporter agents have efficacy for glucose lowering, coupled with weight loss and potential cardiovascular risk reduction.
- Insulin therapy is generally safe and effective